This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Cefepime and Mortality: A Systematic Review and Bayesian Meta-Analysis.
JAMA network open · 2026
Lower Respiratory Tract Infections: Precision Diagnostics.
Critical care clinics · 2026 · senior author
Rapid Microbiological Diagnostics for Sepsis: Narrative Review of Current and Prospective Approaches.
Critical care explorations · 2026 · senior author
Latest funding
- $539,325
Dabigatran for the adjunctive treatment of Staphylococcus aureus bacteremia: the DABI-SNAP nested randomized controlled trial
CIHR · 2024 · Principal investigator
- $1,705,952
A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP)
CIHR · 2024 · Principal investigator
- $932,531
Biomarker Signature-supported Antibiotic Treatment Decisions in ICU (BAST-ICU)
CIHR · 2023 · Co-investigator
33 publications.
Cefepime and Mortality: A Systematic Review and Bayesian Meta-Analysis.
Sohani ZN, Zhong YJ, Afshar A, Assiri BA, Gore G, Cheng MP, Lieu A, Serero J, Hamilton F, Lawandi A, Paul M, Yahav D, Albuquerque AM, Butler-Laporte G, McDonald EG, Lee TC
Lower Respiratory Tract Infections: Precision Diagnostics.
Thivierge-Southidara M, Lawandi A
Rapid Microbiological Diagnostics for Sepsis: Narrative Review of Current and Prospective Approaches.
Harrison LB, Sohani ZN, Lasry D, Cheng MP, Lee TC, Babiker A, Kadri SS, Lawandi A
In vitro exposure to non-antipseudomonal antibiotics (NAPA) induces Pseudomonas aeruginosa resistance to antipseudomonal antibiotics (APA).
Lasry D, Harrison LB, Bamba R, Corsini R, Yansouni CP, Cheng MP, Lee TC, Lawandi A
Systemic Corticosteroids Continue to Reduce Mortality in Severe Community-Acquired Pneumonia: An Updated Meta-Analysis.
Lee TC, Albuquerque AM, Lawandi A, Prosty CJ, Kotani Y, Landoni G, McDonald EG
The combinations of cefazolin with linezolid and cefazolin with clindamycin are indifferent against methicillin-susceptible Staphylococcus aureus.
Mellett M, Van Riel J, Corsini R, Satola S, Lawandi A, Caya C, van Hal S, Lee TC, Papenburg J, Yansouni CP, Babiker A, Cheng MP
Antibiotic synergy against Staphylococcus aureus: a systematic review and meta-analysis.
Mellett M, Lawandi A, Caya C, Lee TC, Babiker A, Papenburg J, Yansouni CP, Cheng MP
Establishing piperacillin-tazobactam susceptibility in ceftriaxone non-susceptible Enterobacterales: comparing disk diffusion, Etest, and VITEK 2 automated minimal inhibitory concentration measurements vs. broth microdilution.
Sohani ZN, Lieu A, Bamba R, Patel M, Paul M, Yahav D, McDonald EG, Lawandi A, Lee TC
Comparison of ciprofloxacin and aminoglycoside susceptibility testing for ceftriaxone non-susceptible Enterobacterales by disk diffusion and VITEK 2 vs. broth microdilution using updated Clinical and Laboratory Standards Institute breakpoints.
Sohani ZN, Lieu A, Semret M, Cheng MP, Simic N, Bamba R, Patel M, Lawandi A, Lee TC
Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation.
Babiker A, Warner S, Li X, Chishti EA, Saad E, Swihart BJ, Dekker JP, Walker M, Lawandi A, Kadri SS, NIH-Antimicrobial Resistance Outcomes Research Initiative
Dabigatran for the adjunctive treatment of Staphylococcus aureus bacteremia: the DABI-SNAP nested randomized controlled trial
Principal investigators: McDonald, Emily G; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Lawandi, Alexander; Lawler, Patrick R; Lee, Todd C; Mertz, Dominik; Paul, Mical; Siegal, Deborah M; Tong, Steven; Walls, Genevieve
Keywords: Adjunctive Therapies; Anticoagulants; Comparative Effectiveness Trial; Desirability Of Ordinal Outcomes Rating; Infectious Diseases; Nested Trials; Platform Trial; Pragmatic Trials; Staph Aureus Bacteremia
A Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP)
Principal investigators: Cheng, Matthew P; Bai, Anthony D; Daley, Peter; Daneman, Nick; Grant, Jennifer; Lawandi, Alexander; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Somayaji, Ranjani; Wuerz, Terence
Keywords: Bacteremia; Bloodstream Infection; Clinical Trial; Oral Antibiotics; Staphylococcus Aureus
Biomarker Signature-supported Antibiotic Treatment Decisions in ICU (BAST-ICU)
Principal investigators: Semret, Makeda; Bourdeau, Francois
Keywords: Antimicrobial Resistance (Amr); Antimicrobial Stewardship; Biomarker; Phase 2 Clinical Trial
Biomarker Signature-supported Antibiotic Treatment Decisions in ICU (BAST-ICU)
Principal investigators: Semret, Makeda; Bourdeau, Francois
Keywords: Antimicrobial Resistance (Amr); Antimicrobial Stewardship; Biomarker; Phase 2 Clinical Trial
Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)
Principal investigators: Lee, Todd C; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Johnstone, Jennie; Lawandi, Alexander; Lye, David C; McDonald, Emily G; Paul, Mical; Tong, Steven; Walls, Genevieve; Wuerz, Terence
Keywords: Combination Therapy; Endocarditis; Randomized Controlled Trial; Staphylococcus Aureus Bacteremia
Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)
Principal investigators: Lee, Todd C; Cheng, Matthew P; Daneman, Nick; Davis, Joshua; Goodman, Anna L; Johnstone, Jennie; Lawandi, Alexander; Lye, David C; McDonald, Emily G; Paul, Mical; Tong, Steven; Walls, Genevieve; Wuerz, Terence
Keywords: Combination Therapy; Endocarditis; Randomized Controlled Trial; Staphylococcus Aureus Bacteremia
Initial vancomycin taper for the prevention of recurrent Clostridium difficile infection
Principal investigators: Lee, Todd C; McDonald, Emily G
Keywords: Clostridium Dificile; Prevention; Recurrence; Vancomycin
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Jesse Papenburg and Jesse Papenburg: 123 shared papers
- Alexander Lawandi and Guillaume Butler-Laporte: 6 shared papers
- Jesse Papenburg and Alexander Lawandi: 3 shared papers
- Jesse Papenburg and Alexander Lawandi: 3 shared papers
- Makeda Semret and Cedric Yansouni: 2 shared papers
- Makeda Semret and Jesse Papenburg: 2 shared papers
- Todd Lee and Alexander Lawandi: 1 shared paper
- Makeda Semret and Jesse Papenburg: 1 shared paper
- Makeda Semret and Alexander Lawandi: 1 shared paper
- Makeda Semret and Guillaume Butler-Laporte: 1 shared paper
- Cedric Yansouni and Jesse Papenburg: 1 shared paper
- Cedric Yansouni and Alexander Lawandi: 1 shared paper
- Bertrand Routy and Jesse Papenburg: 1 shared paper
- Bertrand Routy and Jesse Papenburg: 1 shared paper
- Bertrand Routy and Alexander Lawandi: 1 shared paper
- Infectious Diseases
- Medical Microbiology and Infectious Diseases
- Pediatrics
- Hematology-Oncology
- Dermatology
- Medicine
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Guillaume Butler-Laporte
Infectious Diseases
6 shared papers, latest 2026
Jesse Papenburg
Pediatrics
3 shared papers, latest 2025
Jesse Papenburg
Medical Microbiology and Infectious Diseases
3 shared papers, latest 2025
Todd Lee
Infectious Diseases
1 shared papers, latest 2019
Makeda Semret
Medicine
1 shared papers, latest 2025
Cedric Yansouni
Dermatology
1 shared papers, latest 2024
Bertrand Routy
Hematology-Oncology
1 shared papers, latest 2024
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.